Showing results (31-40 of 814) with videos related to
Sort By:
Pageof 82
BMJ Open Ophthalmology|January 30, 2026
First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network reportAmr Saad, Christina Plasencia, Justus Garweg, et al.BMJ Open Ophthalmology|February 3, 2026
Metformin and incidence of age-related macular degeneration in people with diabetes: a population-based 5-year case-control studyDewi Fathin Romdhoniyyah, Ayesh Alshukri, David G Parry, et al.BMJ Open Ophthalmology|February 2, 2026
Research on eye health 2000-2019: a global bibliometric analysis with a focus on equityJacqueline Ramke, Saad Chugtai, Justas Bezaras, et al.BMJ Open Ophthalmology|January 20, 2026
Ocular diseases and their association with mortality in intensive care unit patients: a retrospective cohort study from the MIMIC-IV databaseChang Gao, Jing Lou, Yuting Hu, et al.BMJ Open Ophthalmology|January 30, 2026
Metastatic disease in conjunctival malignant melanoma: a retrospective analysis of 167 casesMelisa Sezgin, Ahmad Rahal, Veronika Nowack, et al.BMJ Open Ophthalmology|January 27, 2026
Evaluating reasoning large language models with human-like thinking in ophthalmic question answeringZhouqian Wang, Chenjia Xu, Lei Wang, et al.BMJ Open Ophthalmology|March 25, 2025
Associations between certification of visual impairment and socioeconomic deprivation: a study using data from the regional Northern Ireland sight impairment certification databaseNatasha Moore, Laura Cushley, David Wright, et al.BMJ Open Ophthalmology|March 25, 2025
Development of a Sun Protection Factor for contact lenses (CL-SPF)James S Wolffsohn, Tom Drew, Andrew Devitt, et al.BMJ Open Ophthalmology|March 16, 2025
Association of plasma metabolites with treatment response after intravitreal anti-vascular endothelial growth factor injections in treatment-naïve neovascular age-related macular degenerationHae Min Kang, Kevin M Mendez, Inês Laíns, et al.BMJ Open Ophthalmology|December 7, 2018
Prospective pilot study comparing deep sclerectomy outcomes with a long-term and intense corticosteroid treatment versus a standard oneAitor Lanzagorta-Aresti, Marta Perez-Lopez, Juan Maria Davo-Cabrera, et al.Pageof 82